1.29 (2.71%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
CRISPR Therapeutics AG
Telephone
41.41.561.32.77
Address
Baarerstrasse 14, Zug 6300
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 35.41 - 78.47
Trade Value (12mth)
US$95,827.00
1 week
0.65%
1 month
-11.51%
YTD
-7.85%
1 year
29.76%
All time high
216.56
EPS 3 yr Growth
-22.70%
EBITDA Margin
NaN%
Operating Cashflow
-$345m
Free Cash Flow Return
-16.20%
ROIC
-27.40%
Interest Coverage
0.00
Quick Ratio
13.30
Shares Outstanding (Fully Diluted)
96m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | GBP |  | | | | -1.94 | -4.34 | -6.47 | | | | ||
EPS (Fully Diluted) | GBP | | | | | -1.94 | -4.34 | -6.47 | | | | ||
Growth | % | | | | | 76.8 | -123.9 | -49 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
